Motus gi holdings, inc. announces exercise of warrants for $2.7 million gross proceeds

Fort lauderdale, fla., feb. 22, 2024 (globe newswire) -- motus gi holdings, inc. (nasdaq: mots, or “motus” or “the company”), a medical technology company focused on improving endoscopic outcomes and experiences, today announced that it has entered into a definitive agreement for the immediate exercise of an outstanding series b common stock purchase warrant held by an institutional investor to purchase an aggregate of 2,933,334 shares of the company's common stock for gross proceeds to the company of approximately $2.7 million.
MOTS Ratings Summary
MOTS Quant Ranking